← Evidence map

ArticleCancer2025

Imatinib dose reduction after major molecular response in chronic-phase chronic myeloid leukemia.

Zongru Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 39305107